Biogen sees flat 2024 sales, pick up in Alzheimer’s drug demand
By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product revenue...
By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product revenue...
(Reuters) – Shares of Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and...
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit on Tuesday,...
(Reuters) – Global investors accumulated money market funds for a third straight week in the...
By Bhanvi Satija and Mariam Sunny (Reuters) -Walgreens Boots Alliance on Thursday nearly halved its...
By Nate Raymond (Reuters) – Consulting firm McKinsey & Co has agreed to pay $78...
By Brendan Pierson (Reuters) – Bayer has won a trial in a lawsuit brought by...
(Reuters) – Investors pulled back sharply from global bond funds in the seven days through...
By Anirban Sen (Reuters) -U.S. health insurer Cigna has ended its attempt to negotiate an...
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson on Tuesday forecast revenue growth...